In experimental diabetic neuropathy, treatment with IGF-1 reversed neuronal hyperactivity in the spinal cord and in the periaqueductal gray matter and prevented behavioral signs of pain [48]. The gene discussed is IGF1; the disease is diabetic neuropathy.